AdvaMed Accel Targets 400+ Startups at Boston MedTech Conference
Boston – October 17, 2026 -- AdvaMed is steering its more than 400 small and emerging medtech members toward The MedTech Conference, October 18–21 in Boston, where it expects over 4,000 attendees and 1,800 companies.
JC Scott, who has returned to the trade association as Chief Strategy Officer, also leads AdvaMed Accel as Executive Director. Accel is the association's dedicated division for emerging members, offering advocacy, access and community.
Partnering platform compresses investor outreach into days
Full Access attendees and Full Access exhibitors can use the Partnering platform to book one-on-one meetings with investors, collaborators, potential customers and strategic partners. Scott says conversations that might otherwise take months to arrange can happen over a few days. AdvaMed has published a 2026 investor list for preview.